Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Targeting DNA Repair to Overcome Drug Resistance in Hodgkin Lymphoma

Julie Devin, PharmD, Quentin Denis, Caroline Bret, PhD PharmD, Jerome Moreaux, PhD

Blood (2020) 136 (Supplement 1): 26.

https://doi.org/10.1182/blood-2020-142510

Published: 2020

Journal Articles

DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic Targets

Ludovic Gabellier, MD, Caroline Bret, PhD PharmD, Guillaume Bossis, PhD, Guillaume Cartron, MD PhD, Jerome Moreaux, PhD

Blood (2020) 136 (Supplement 1): 35.

https://doi.org/10.1182/blood-2020-137417

Published: 2020

Journal Articles

Comprehensive Characterization of the Epigenetic Landscape in Multiple Myeloma

Elina Alaterre, PhD, Laurie Herviou, Hugues De Boussac, PhD, Giorgio Papadopoulos, PhD, Stéphanie Boireau, Nicolas Robert, Guilhem Requirand, Angelique Bruyer, Sara Ovejero-Merino, PhD, Laure Vincent, Anne Marie Martinez, Giacomo Cavalli, PhD, Jerome Moreaux, PhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-138801

Published: 2020

Journal Articles

Robust Discovery of Candidate DNA Methylation Cancer Drivers

Heng Pan, PhD, Loïc Renaud, MD MSc, Ronan Chaligne, PhD, Johannes Bloehdorn, MD, Eugen Tausch, MD, Daniel Mertens, PhD, Anna-Maria Fink, MD, Kirsten Fischer, MD, Chao Zhang, PhD, Doron Betel, PhD, Andreas Gnirke, Marcin Imielinski, Jerome Moreaux, PhD, Michael Hallek, Alexander Meissner, PhD, Stephan Stilgenbauer, MD, Catherine J. Wu, MD, Olivier Elemento, PhD, Dan A. Landau, MD PhD

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-136830

Published: 2020

Journal Articles

RNA-Sequencing Based Assessment of Targets, Risk and Long Term Survival for Personalized Treatment of Multiple Myeloma

Martina Emde, Susanne Beck, Vladimir Benes, Jerome Moreaux, PhD, Anja Seckinger, Dirk Hose, MD

Blood (2019) 134 (Supplement_1): 1801.

https://doi.org/10.1182/blood-2019-131159

Published: 2019

Journal Articles

Prediction of Malingant Plasma Cell Biology Related Survival in AL-Amyloidosis

Susanne Beck, Martina Emde, Jerome Moreaux, PhD, Anja Seckinger, Dirk Hose, MD

Blood (2019) 134 (Supplement_1): 3078.

https://doi.org/10.1182/blood-2019-131161

Published: 2019

Journal Articles

Ironomycin Induces Diffuse Large B-Cell Lymphoma Cell Death By Targeting Iron Metabolism Addiction

Julie Devin, PharmD, Tatiana Cañeque, Yea-Lih Lin, PhD, Guillaume Cartron, Philippe Pasero, PhD, Caroline Bret, PhD PharmD, Raphael Rodriguez, Jerome Moreaux, PhD

Blood (2019) 134 (Supplement_1): 3960.

https://doi.org/10.1182/blood-2019-129954

Published: 2019

Journal Articles

Histone Methyltransferases G9a and GLP; Identification and Validation of Novel Therapeutic Targets for Multiple Myeloma Treatment

Eva De Smedt, Julie Devin, Hui Liu, Anke Maes, Ken Maes, Kim De Veirman, Eline Menu, PhD, Karin Vanderkerken, PhD, Jerome Moreaux, PhD, Elke De Bruyne, PhD

Blood (2017) 130 (Supplement 1): 4356.

https://doi.org/10.1182/blood.V130.Suppl_1.4356.4356

Published: 2017

Journal Articles

CD200 Is a Potent New Growth Factor in Multiple Myeloma through IGF-1R Interaction

Angélique Bruyer, MSc, Nicolas Robert, Stéphanie Boireau, Christophe Hirtz, Laurent Tiers, Laure Vincent, Guillaume Cartron, Dirk Hose, MD, Anja Seckinger, Bernard Klein, PhD, Jerome Moreaux, PhD

Blood (2017) 130 (Supplement 1): 3045.

https://doi.org/10.1182/blood.V130.Suppl_1.3045.3045

Published: 2017

Journal Articles

Targeting DNA Repair Mechanisms to Overcome Drug Resistance in Diffuse Large B Cell Lymphoma

Julie Devin, Yea-Lih Lin, PhD, Alboukadel Kassambara, PhD, Guillaume Cartron, Olivier Elemento, PhD, Angelos Constantinou, PhD, Philippe Pasero, PhD, Caroline Bret, PhD PharmD, Jerome Moreaux, PhD

Blood (2017) 130 (Supplement 1): 1479.

https://doi.org/10.1182/blood.V130.Suppl_1.1479.1479

Published: 2017

Journal Articles

Combined Inhibition of Chk1 and Wee1 As a New Therapeutic Strategy for High-Risk Multiple Myeloma Patients

Angelique Bruyer, Hugues de Boussac, PhD, Thibaut Martin, Alboukadel Kassambara, PhD, Nicolas Robert, Guillaume Cartron, Dirk Hose, MD, Anja Seckinger, Philippe Pasero, PhD, Jerome Moreaux, PhD

Blood (2017) 130 (Supplement 1): 1777.

https://doi.org/10.1182/blood.V130.Suppl_1.1777.1777

Published: 2017

Journal Articles

RNA Sequencing Data-Driven Dissection of Human Plasma Cell Differentiation Reveals New Potential Transcription Regulators

Alboukadel Kassambara, PhD, Laurie Herviou, Michel Jourdan, Coraline Thibaut, Veronika Vikova, Olivier Elemento, PhD, Jerome Moreaux, PhD

Blood (2017) 130 (Supplement 1): 4382.

https://doi.org/10.1182/blood.V130.Suppl_1.4382.4382

Published: 2017

Journal Articles

Kinome Expression Profiling in Multiple Myeloma Identifies New Therapeutic Targets

Hugues de Boussac, PhD, Angelique Bruyer, Nicolas Robert, Anke Maes, Laure Vincent, Anja Seckinger, Guillaume Cartron, Dirk Hose, MD, Elke De Bruyne, PhD, Alboukadel Kassambara, PhD, Jerome Moreaux, PhD

Blood (2017) 130 (Supplement 1): 1766.

https://doi.org/10.1182/blood.V130.Suppl_1.1766.1766

Published: 2017

Journal Articles

Targeting EZH2 in Multiple Myeloma Could be Promising for a Subgroup of MM Patients in Combination with IMiDs

Laurie Herviou, Alboukadel Kassambara, PhD, Stephanie Boireau, PhD, Nicolas Robert, Guilhem Requirand, Laure Vincent, MD, Anja Seckinger, MD, Hartmut Goldschmidt, MD, Dirk Hose, MD, Giacomo Cavalli, PhD, Jerome Moreaux, PhD

Blood (2016) 128 (22): 311.

https://doi.org/10.1182/blood.V128.22.311.311

Published: 2016

Journal Articles

Identification of a Gene Signature Associated to Treatment Response to Palbociclib in Multiple Myeloma

Angelique Bruyer, Alboukadel Kassambara, PhD, Paul Anziani, Donia El Bahlagui, Nicolas Robert, Laure Vincent, MD, Bernard Klein, Jerome Moreaux, PhD

Blood (2016) 128 (22): 5666.

https://doi.org/10.1182/blood.V128.22.5666.5666

Published: 2016

Journal Articles

On the Redox Profile of B- Cell Terminal Differentiation and Multiple Myeloma: New Insights and Therapeutic Opportunities

Wafa Hassen, PhD, Alboukadel Kassambara, PhD, Michel Jourdan, Stephanie Boireau, PhD, Anja Seckinger, MD, Dirk Hose, Yubin Kang, MD, Bernard Klein, Jerome Moreaux, PhD

Blood (2016) 128 (22): 5644.

https://doi.org/10.1182/blood.V128.22.5644.5644

Published: 2016

Journal Articles

A Small Molecule That Selectively Targets BLM Helicase Has a Therapeutic Interest in Multiple Myeloma

Elena Viziteu, Yea Lih Lin, Laure Vincent, MD, Anja Seckinger, MD, Dirk Hose, Angelos Constantinou, Bernard Klein, Philippe Pasero, PhD, Jerome Moreaux, PhD

Blood (2016) 128 (22): 4433.

https://doi.org/10.1182/blood.V128.22.4433.4433

Published: 2016

Journal Articles

SET8 Is a Potential Therapeutic Target in MM

Herviou Laurie, Fanny Izard, Elke De Bruyne, PhD, Eva Desmedt, Anqi Ma, PhD, Jian Jin, PhD, Karin Vanderkerken, PhD, Eric Julien, Jerome Moreaux, PhD

Blood (2016) 128 (22): 4435.

https://doi.org/10.1182/blood.V128.22.4435.4435

Published: 2016

Journal Articles

RAS Association Domain Family Member 4 (RASSF4): A New Potent Tumor Suppressor in Multiple Myeloma

Eva De Smedt, Ken Maes, PhD, Stefan Verhulst, Hui Lui, Alboukadel Kassambara, PhD, Anke Maes, Dirk Hose, MD, Karine Breckpot, Jerome Moreaux, PhD, Elke De Bruyne, PhD

Blood (2016) 128 (22): 2057.

https://doi.org/10.1182/blood.V128.22.2057.2057

Published: 2016

Journal Articles

Patterns of Microrna in Plasma Cells: From Normal Differentiation to Multiple Myeloma

Alboukadel Kassambara, PhD, Angelique Bruyer, Michel Jourdan, Nicolas Robert, Véronique Pantesco, Olivier Elemento, PhD, Bernard Klein, Jerome Moreaux, PhD

Blood (2016) 128 (22): 2069.

https://doi.org/10.1182/blood.V128.22.2069.2069

Published: 2016

NARROW

Targeting DNA Repair to Overcome Drug Resistance in Hodgkin Lymphoma

DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic Targets

Comprehensive Characterization of the Epigenetic Landscape in Multiple Myeloma

Robust Discovery of Candidate DNA Methylation Cancer Drivers

RNA-Sequencing Based Assessment of Targets, Risk and Long Term Survival for Personalized Treatment of Multiple Myeloma

Prediction of Malingant Plasma Cell Biology Related Survival in AL-Amyloidosis

Ironomycin Induces Diffuse Large B-Cell Lymphoma Cell Death By Targeting Iron Metabolism Addiction

Histone Methyltransferases G9a and GLP; Identification and Validation of Novel Therapeutic Targets for Multiple Myeloma Treatment

CD200 Is a Potent New Growth Factor in Multiple Myeloma through IGF-1R Interaction

Targeting DNA Repair Mechanisms to Overcome Drug Resistance in Diffuse Large B Cell Lymphoma

Combined Inhibition of Chk1 and Wee1 As a New Therapeutic Strategy for High-Risk Multiple Myeloma Patients

RNA Sequencing Data-Driven Dissection of Human Plasma Cell Differentiation Reveals New Potential Transcription Regulators

Kinome Expression Profiling in Multiple Myeloma Identifies New Therapeutic Targets

Targeting EZH2 in Multiple Myeloma Could be Promising for a Subgroup of MM Patients in Combination with IMiDs

Identification of a Gene Signature Associated to Treatment Response to Palbociclib in Multiple Myeloma

On the Redox Profile of B- Cell Terminal Differentiation and Multiple Myeloma: New Insights and Therapeutic Opportunities

A Small Molecule That Selectively Targets BLM Helicase Has a Therapeutic Interest in Multiple Myeloma

SET8 Is a Potential Therapeutic Target in MM

RAS Association Domain Family Member 4 (RASSF4): A New Potent Tumor Suppressor in Multiple Myeloma

Patterns of Microrna in Plasma Cells: From Normal Differentiation to Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only